CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 28, 2013	Dec. 29, 2012
Cash flows from operating activities
Net income	$ 500,447	$ 296,501
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	55,687	39,081
Loss on disposal of fixed assets	2,135	176
Unrealized foreign exchange loss	279	837
Income earned on joint venture	(125)
Amortization of deferred financing costs	560	531
Amortization of deferred rent	5,116	2,109
Deferred income taxes	2,507	557
Equity compensation expense	20,919	15,205
Tax benefits on exercise of share options	(44,731)	(128,766)
Non-cash charges for services provided by former parent		448
Change in assets and liabilities:
Receivables, net	(83,994)	(45,381)
Inventories	(162,230)	(102,635)
Prepaid expenses and other current assets	(5,250)	49,358
Other assets	(6,063)	(1,125)
Accounts payable	62,028	38,089
Accrued expenses and other current liabilities	84,824	74,408
Other long-term liabilities	17,734	9,774
Net cash provided by operating activities	449,843	249,167
Cash flows from investing activities
Capital expenditures	(126,942)	(74,835)
Equity method investments		(3,232)
Purchase of intangible assets	(21,962)	(3,619)
Net cash used in investing activities	(148,904)	(81,686)
Cash flows from financing activities
Repayments of borrowings under revolving credit agreement	(21,120)	(38,954)
Borrowings under revolving credit agreement	21,120	16,280
Exercise of employee share options	13,535	25,756
Purchase of Treasury Shares	(2,447)
Tax benefits on exercise of share options	44,731	128,766
Payment of deferred financing costs	(176)	(60)
Net cash provided by financing activities	55,643	131,788
Effect of exchange rate changes on cash and cash equivalents	(752)	153
Net increase in cash and cash equivalents	355,830	299,422
Beginning of period	472,511	106,354
End of period	828,341	405,776
Supplemental disclosures of cash flow information
Cash paid for interest	513	400
Cash paid for income taxes	206,552	54,058
Supplemental disclosure of noncash investing and financing activities
Accrued capital expenditures	$ 18,635	$ 16,444